Breast Cancer

Breast Cancer

42 items identified
AbemaImmune (Breast Cancer)
Alliance A011202 (Breast Cancer)
ASPIRe: A Study for New Imaging Technology to Assist in Reconstructive Surgeries
ATEMPT 2.0 for Early stage HER2+ Breast Cancer
Aurora Prospective: A Biorepository Study for Metastatic Breast Cancer
BMS CA209-7FL: Nivolumab or Placebo with Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy
Breast cancer blood/tissue repository and database
Breast Pre Cancer Atlas
Breast Tumor MicroEnvironment Study (TME)
Bullseye ultrasound for lymphedema measurement
BYL719C2202 EPIK-B4 in HR-positive, HER2-negative advanced breast cancer with PIK3CA mutation
Color Study (High-Risk Breast Lesions)
COMET: Ductal Carcinoma in SITU
COMPASS HER2+ Breast with Residual Disease (A011801)
Concurrent VRP-HER2 Vaccine + Pembrolizumab for HER2+ Breast Cancer
Coping Together-2 (Cancer Support)
CROWN Study (Breast Cancer)
Destiny 11 for Early Stage HER2 + Breast Cancer
DESTINY-Breast07 in HER2-positive metastatic breast cancer
Early detection of breast cancer using circulating markers
Effects of Endocrine Therapies in Early Stage ER+ Breast Cancer
ESR1 peptides vaccine study (Breast Cancer)
Fox Chase BR-076 (Triple Negative Breast Cancer)
Improving Well-Being for Breast Cancer Patients
JZLA EMBER: A Phase 1 Study for Metastatic ER+/HER2+ Breast Cancer (Part C)
Lumicell in Breast Cancer Patients
MEM-288 (solid tumors)
MODEL ABC (Breast Cancer)
NIT-110 (Solid tumors)
OncoCHAT (Advanced Solid Cancer)
P-Rad in Node-Positive HER2-Negative Breast Cancer
Phyllodes Gene Testing (Phyllodes Tumors of the Breast)
pING-HER3 Vaccine for Cancer
PVSRIPO Bioactivity Invasive Breast Cancer
Rare Breast Tumor Registry
REMD 477 for Metastatic ER+ Breast Cancer with PIK3CA Mutation
TBCRC 047: InCITe (Breast Cancer)
TBCRC045-AVIATOR for HER2+ Metastatic Breast Cancer
TBCRC048: Metastatic Breast Cancer, BRCA Gene Mutation
TMIST Mammography Study (Breast Cancer Screening)
Well-Being ABCs (Well-Being After Breast Surgery)
X-PACT Immunolight (Breast Cancer, Head & Neck Cancer, Melanoma, and Sarcoma)